|
Volumn 308, Issue 5721, 2005, Pages 477-
|
Industry-academic drug screening plan targets CJD
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
PRION PROTEIN;
DRUG DEVELOPMENT;
MEDICINE;
BOVINE SPONGIFORM ENCEPHALOPATHY;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CREUTZFELDT JAKOB DISEASE;
DRUG INDUSTRY;
DRUG PROGRAM;
GENERAL CONDITION DETERIORATION;
HUMAN;
LABORATORY TEST;
MEDICAL EXPERT;
NOTE;
PRIORITY JOURNAL;
ANIMAL;
ARTICLE;
DRUG SCREENING;
UNITED KINGDOM;
BOVINAE;
ANIMALS;
CREUTZFELDT-JAKOB SYNDROME;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
GREAT BRITAIN;
HUMANS;
|
EID: 17844391797
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (0)
|